Language: Spanish
References: 9
Page: 395-398
PDF size: 259.38 Kb.

Text Extraction

No abstract.

REFERENCES

1. Sebia. HYDRAGEL IF K20. 2011/02.

2. Bird JM, Owen RG, D’Sa S, Snowden JA, Pratt G, Ashcroft J, et al. Guidelines for the diagnosis and management of multiple myeloma 2011. Br J Haematol 2011; 154: 32-75.

3. Munshi NC. Investigative tools for diagnosis and management. Hematology Am Soc Hematol Educ Program 2008: 298-305.

4. Durie BG, Harousseau JL, Miguel JS, Blade J, Barlogie B, Anderson K, et al. International uniform response criteria for multiple myeloma. Leukemia 2006; 20: 1467-1473.

5. Kyle RA, Rajkumar SV. Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009; 23: 3-9.

6. Jaffe ES, Harris NL, Vardiman JW, Campo E, Arber DA. Hematopathology. Philadelphia: Elsevier Saunders; 2011.

7. Feller AC, Diebold J. Histopathology of Nodal and Extranodal Non-Hodgkin’s Lymphomas (ed 3rd). Berlin: Springer-Verlag; 2004.

8. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, et al. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem 2002; 48: 1437-1444.

9. Jaskowski TD, Litwin CM, Hill HR. Detection of kappa and lambda light chain monoclonal proteins in human serum: automated immunoassay versus immunofixation electrophoresis. Clin Vaccine Immunol 2006; 13: 277-280.